Hubbry Logo
LeukoplakiaLeukoplakiaMain
Open search
Leukoplakia
Community hub
Leukoplakia
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Leukoplakia
Leukoplakia
from Wikipedia
Leukoplakia
Other namesLeucoplakia,[1] leukokeratosis,[1] idiopathic leukoplakia,[2] leukoplasia,[1] idiopathic keratosis,[3] idiopathic white/gray patch[3]
Leukoplakia on the inside of the cheek
SpecialtyOral and maxillofacial surgery, Oral medicine, Dentistry
SymptomsFirmly attached white/gray patch on a mucous membrane, changes with time,[4][5][6] Tongue with a white or light gray color
ComplicationsSquamous cell carcinoma[4]
Usual onsetAfter 30 years old[4]
CausesUnknown[6]
Risk factorsSmoking, chewing tobacco, excessive alcohol, betel nuts[4][7]
Diagnostic methodMade after other possible causes ruled out, tissue biopsy[6]
Differential diagnosisYeast infection, lichen planus, keratosis due to repeated minor trauma[4]
TreatmentClose follow up, stop smoking, limit alcohol, surgical removal[4]
FrequencyUp to 8% of men over 70[6]

Oral leukoplakia is a potentially malignant disorder affecting the oral mucosa. It is defined as "essentially an oral mucosal white/gray lesion that cannot be considered as any other definable lesion." Oral leukoplakia is a gray patch or plaque that develops in the oral cavity and is strongly associated with smoking.[8] Leukoplakia is a firmly attached white patch on a mucous membrane which is associated with increased risk of cancer.[4][5] The edges of the lesion are typically abrupt and the lesion changes with time.[4][6] Advanced forms may develop red patches.[6] There are generally no other symptoms.[9] It usually occurs within the mouth, although sometimes mucosa in other parts of the gastrointestinal tract, urinary tract, or genitals may be affected.[10][11][12]

The cause of leukoplakia is unknown.[6] Risk factors for formation inside the mouth include smoking, chewing tobacco, excessive alcohol, and use of betel nuts.[4][7] One specific type is common in HIV/AIDS.[13] It is a precancerous lesion, a tissue alteration in which cancer is more likely to develop.[4] The chance of cancer formation depends on the type, with between 3–15% of localized leukoplakia and 70–100% of proliferative leukoplakia developing into squamous cell carcinoma.[4]

Leukoplakia is a descriptive term that should only be applied after other possible causes are ruled out.[6] Tissue biopsy generally shows increased keratin build up with or without abnormal cells, but is not diagnostic.[4][6] Other conditions that can appear similar include yeast infections, lichen planus, and keratosis due to repeated minor trauma.[4] The lesions from a yeast infection can typically be rubbed off while those of leukoplakia cannot.[4][14]

Treatment recommendations depend on features of the lesion.[4] If abnormal cells are present or the lesion is small surgical removal is often recommended; otherwise close follow up at three to six month intervals may be sufficient.[4] People are generally advised to stop smoking and limit the drinking of alcohol.[3] In potentially half of cases leukoplakia will shrink with stopping smoking;[5] however, if smoking is continued up to 66% of cases will become more white and thick.[6] The percentage of people affected is estimated at 1–3%.[4] Leukoplakia becomes more common with age, typically not occurring until after 30.[4] Rates may be as high as 8% in men over the age of 70.[6]

Classification

[edit]
Leukoplakia in the lower labial sulcus
Leukoplakia of the soft palate
Exophytic leukoplakia on the buccal mucosa
Leukoplakia on the side of tongue

Leukoplakia could be classified as mucosal disease, and also as a premalignant condition. Although the white color in leukoplakia is a result of hyperkeratosis (or acanthosis), similarly appearing white lesions that are caused by reactive keratosis (smoker's keratosis or frictional keratoses e.g. morsicatio buccarum) are not considered to be leukoplakias.[15] Leukoplakia could also be considered according to the affected site, e.g. oral leukoplakia, leukoplakia of the urinary tract, including bladder leukoplakia or leukoplakia of the penis, vulvae, cervix or vagina.[16][17] Leukoplakia may also occur in the larynx, possibly in association with gastro-esophageal reflux disease.[18] Oropharyngeal leukoplakia is linked to the development of esophageal squamous cell carcinoma,[18] and sometimes this is associated with tylosis, which is thickening of the skin on the palms and soles of the feet (see: Leukoplakia with tylosis and esophageal carcinoma). Dyskeratosis congenita may be associated with leukoplakia of the oral mucosa and of the anal mucosa.[18]

Mouth

[edit]

Within the mouth, leukoplakia is sometimes further classified according to the site involved, e.g. leukoplakia buccalis (leukoplakia of the buccal mucosa) or leukoplakia lingualis (leukoplakia of the lingual mucosa). There are two main clinical variants of oral leukoplakia, namely homogeneous leukoplakia and non-homogeneous (heterogenous) leukoplakia, which are described below. The word leukoplakia is also included within the nomenclature of other oral conditions which present as white patches, however, these are specific diagnoses that are generally considered separate from leukoplakia, with the notable exception of proliferative verrucous leukoplakia, which is a recognized sub-type of leukoplakia.

Homogeneous leukoplakia

[edit]

Homogeneous leukoplakia (also termed "thick leukoplakia")[2] is usually well defined white patch of uniform, flat appearance and texture, although there may be superficial irregularities.[2][9] Homogeneous leukoplakia is usually slightly elevated compared to surrounding mucosa, and often has a fissured, wrinkled or corrugated surface texture,[2] with the texture generally consistent throughout the whole lesion. This term has no implications on the size of the lesion, which may be localized or extensive.[2] When homogeneous leukoplakia is palpated, it may feel leathery, dry, or like cracked mud.[2]

Non-homogeneous leukoplakia

[edit]

Non-homogeneous leukoplakia is a lesion of non-uniform appearance. The color may be predominantly white or a mixed white and red. The surface texture is irregular compared to homogeneous leukoplakia, and may be flat (papular), nodular or exophytic.[9][15] "Verrucous leukoplakia" (or "verruciform leukoplakia") is a descriptive term used for thick, white, papillary lesions. Verrucous leukoplakias are usually heavily keratinized and are often seen in elderly people. Some verrucous leukoplakias may have an exophytic growth pattern,[2] and some may slowly invade surrounding mucosa, when the term proliferative verrucous leukoplakia may be used. Non-homogeneous leukoplakias have a greater risk of cancerous changes than homogeneous leukoplakias.[9]

Proliferative verrucous leukoplakia
[edit]

Proliferative verrucous leukoplakia (PVL) is a recognized high risk subtype of non-homogeneous leukoplakia.[19] It is uncommon, and usually involves the buccal mucosa and the gingiva (the gums).[20] This condition is characterized by (usually) extensive, papillary or verrucoid keratotic plaques that tends to slowly enlarge into adjacent mucosal sites.[1][2] An established PVL lesion is usually thick and exophytic (prominent), but initially it may be flat.[20] Smoking does not seem to be as strongly related as it is to leukoplakia generally, and another dissimilarity is the preponderance for women over 50.[20] There is a very high risk of dysplasia, transformation to squamous cell carcinoma with high mortality (PVL does not transform into verrucous carcinoma, which is a lesion with a good prognosis usually; the similarity of names does not reflect the common origin, but only the resemblance of their appearance).[2][21]

Erythroleukoplakia
[edit]
Erythroleukoplakia ("speckled leukoplakia"), left commissure. Biopsy showed mild epithelial dysplasia and candida infection. Antifungal medication may turn this type of lesion into a homogeneous leukoplakia (i.e. the red areas would disappear)

Erythroleukoplakia (also termed speckled leukoplakia, erythroleukoplasia or leukoerythroplasia) is a non-homogeneous lesion of mixed white (keratotic) and red (atrophic) color. Erythroplakia (erythroplasia) is an entirely red patch that cannot be attributed to any other cause. Erythroleukoplakia can therefore be considered a variant of either leukoplakia or erythroplakia since its appearance is midway between.[22] Erythroleukoplakia frequently occurs on the buccal mucosa in the commissural area (just inside the cheek at the corners of the mouth) as a mixed lesion of white nodular patches on an erythematous background,[22] although any part of the mouth may be affected. Erythroleukoplakia and erythroplakia have a higher risk of cancerous changes than homogeneous leukoplakia.[22]

Sublingual keratosis

[edit]
Homogeneous leukoplakia in the floor of the mouth in a smoker. Biopsy showed hyperkeratosis

Sometimes leukoplakia of the floor of mouth or under the tongue is called sublingual keratosis,.[19] though this is not universally accepted to be a distinct clinical entity from idiopathic leukoplakia generally,[19] as it is distinguished from the latter by location only.[3] Usually sublingual keratoses are bilateral and possess a parallel-corrugated, wrinkled surface texture described as "ebbing tide".[3]

Candidal leukoplakia

[edit]

Candidal leukoplakia is usually considered to be a largely historical synonym for a type of oral candidiasis, now more commonly termed chronic hyperplastic candidiasis, rather than a subtype of true leukoplakia.[23] However, some sources use this term to refer to leukoplakia lesions that become colonized secondarily by Candida species, thereby distinguishing it from hyperplastic candidiasis.[19]

Oral hairy leukoplakia

[edit]

Oral hairy leukoplakia is a corrugated ("hairy") white lesion on the sides of the tongue caused by opportunistic infection with Epstein-Barr virus on a systemic background of immunodeficiency, almost always human immunodeficiency virus (HIV) infection.[15] This condition is not considered to be a true idiopathic leukoplakia since the causative agent has been identified. It is one of the most common oral lesions associated with HIV infection, along with pseudomembraneous candidiasis.[13] The appearance of the lesion often heralds the transition from HIV to acquired immunodeficiency syndrome (AIDS).[13]

Syphilitic leukoplakia

[edit]

This term refers to a white lesion associated with syphilis, specifically in the tertiary stage of the infection.[15] It is not considered to be a type of idiopathic leukoplakia, since the causative agent Treponema pallidum is known. It is now rare, but when syphilis was more common, this white patch usually appeared on the top surface of the tongue and carried a high risk of cancerous changes.[19] It is unclear if this lesion was related to the condition itself or whether it was caused by the treatments for syphilis at the time.[24]

Esophagus

[edit]

Leukoplakia of the esophagus is rare compared to oral leukoplakia. The relationship with esophageal cancer is unclear because the incidence of esophageal leukoplakia is so low. It usually appears as a small, nearly opaque white lesion that may resemble early esophageal squamous cell carcinoma. The histologic appearance is similar to oral leukoplakia, with hyperkeratosis and possible dysplasia.[25]

Bladder

[edit]

In the context of lesions of the mucous membrane lining of the bladder, leukoplakia is a historic term for a visualized white patch which histologically represents keratinization in an area of squamous metaplasia. The symptoms may include frequency, suprapubic pain (pain felt above the pubis), hematuria (blood in the urine), dysuria (difficult urination or pain during urination), urgency, and urge incontinence. The white lesion may be seen during cystoscopy, where it appears as a whitish-gray or yellow lesion, on a background of inflamed urothelium and there may be floating debris in the bladder. Leukoplakia of the bladder may undergo cancerous changes, so biopsy and long term follow up are usually indicated.[26]

Anal canal

[edit]

Leukoplakia of the anal canal is rare.[27] It may extend up to the anorectal junction. On digital examination it feels hard and granular, and at proctoscopy, it appears as white plaques which may be diffuse, circumferential, or circumscribed. The histologic appearance is similar to oral leukoplakia, with hyperkeratosis and acanthosis. It may be asymptomatic, with symptoms due to other lesions such as hemorrhoids or fissures. Progression to anal stenosis has been described. The malignant potential is seemingly low, and few cases of anal carcinoma have been reported associated with anal leukoplaka.[28]

Signs and symptoms

[edit]

Most cases of leukoplakia cause no symptoms,[9] but infrequently there may be discomfort or pain.[2] The exact appearance of the lesion is variable. Leukoplakia may be white, whitish yellow or grey.[29] The size can range from a small area to much larger lesions.[29] The most common sites affected are the buccal mucosa, the labial mucosa and the alveolar mucosa,[30] although any mucosal surface in the mouth may be involved.[2] The clinical appearance, including the surface texture and color, may be homogeneous or non-homogeneous (see: classification). Some signs are generally associated with a higher risk of cancerous changes (see: prognosis).

Leukoplakia may rarely be associated with esophageal carcinoma.[31]: 805 

Causes

[edit]

The exact underlying cause of leukoplakia is largely unknown,[1] but it is likely multifactorial, with the main factor being the use of tobacco.[29] Tobacco use and other suggested causes are discussed below. The mechanism of the white appearance is thickening of the keratin layer, called hyperkeratosis. The abnormal keratin appears white when it becomes hydrated by saliva, and light reflects off the surface evenly.[29] This hides the normal pink-red color of mucosae (the result of underlying vasculature showing through the epithelium).[1] A similar situation can be seen on areas of thick skin such as the soles of the feet or the fingers after prolonged immersion in water. Another possible mechanism is thickening of the stratum spinosum, called acanthosis.[29]

Tobacco

[edit]

Tobacco smoking or chewing is the most common causative factor,[29] with more than 80% of persons with leukoplakia having a positive smoking history.[1] Smokers are much more likely to develop leukoplakia than non-smokers.[1] The size and number of leukoplakia lesions in an individual is also correlated with the level of smoking and how long the habit has lasted for.[1] Other sources argue that there is no evidence for a direct causative link between smoking and oral leukoplakia.[32] Cigarette smoking may produce a diffuse leukoplakia of the buccal mucosa, lips, tongue and rarely the floor of mouth.[29] Reverse smoking, where the lit end of the cigarette is held in the mouth is also associated with mucosal changes.[29] Tobacco chewing, e.g. betel leaf and areca nut, called paan, tends to produce a distinctive white patch in a buccal sulcus termed "tobacco pouch keratosis".[1] In the majority of persons, cessation triggers shrinkage or disappearance of the lesion, usually within the first year after stopping.[1][29]

Alcohol

[edit]

Although the synergistic effect of alcohol with smoking in the development of oral cancer is beyond doubt, there is no clear evidence that alcohol is involved in the development of leukoplakia, but it does appear to have some influence.[29] Excessive use of a high alcohol-containing mouth wash (> 25%) may cause a grey plaque to form on the buccal mucosa, but these lesions are not considered true leukoplakia.[1]

Sanguinaria

[edit]

Sanguinaria (Bloodroot) is a herbal extract that is included in some toothpastes and mouthwashes. Its use is strongly associated with development of leukoplakia, usually in the buccal sulcus.[33] This type of leukoplakia has been termed "sanguinaria associated keratosis" and more than 80% of people with leukoplakia in the vestibule of the mouth have used this substance. Upon stopping contact with the causative substance, the lesions may persist for many years. Although this type of leukoplakia may show dysplasia, the potential for malignant transformation is unknown.[1]

Ultraviolet radiation

[edit]

Ultraviolet radiation is believed to be a factor in the development of some leukoplakia lesions of the lower lip, usually in association with actinic cheilitis.[1]

Micro-organisms

[edit]

Candida in its pathogenic hyphal form is occasionally seen in biopsies of idiopathic leukoplakia. It is debated whether candida infection is a primary cause of leukoplakia with or without dysplasia, or a superimposed (secondary) infection that occurs after the development of the lesion. It is known that Candida species thrive in altered tissues.[29] Some leukoplakias with dysplasia reduce or disappear entirely following use of antifungal medication.[1] Smoking, which as discussed above can lead to the development of leukoplakia, can also promote oral candidiasis.[1] Candida in association with leukoplakia should not be confused with white patches which are primarily caused by candida infection, such as chronic hyperplastic candidiasis ("candidal leukoplakia").[19]

The involvement of viruses in the formation of some oral white lesions is well established, e.g. Epstein-Barr virus in oral hairy leukoplakia (which is not a true leukoplakia). Human papilloma virus (HPV), especially HPV 16 and 18,[1] is sometimes found in areas of leukoplakia, however, since this virus can be coincidentally found on normal, healthy mucosal surfaces in the mouth, it is unknown if this virus is involved in the development of some leukoplakias.[29][34] In vitro experimentation has demonstrated that HPV 16 is capable of inducing dysplastic changes in previously normal squamous epithelium.[1]

Epithelial atrophy

[edit]

Leukoplakia is more likely to develop in areas of epithelial atrophy. Conditions associated with mucosal atrophy include iron deficiency, some vitamin deficiencies, oral submucous fibrosis, syphilis and sideropenic dysphagia.[29]

Trauma

[edit]

Another very common cause of white patches in the mouth is frictional or irritational trauma leading to keratosis. Examples include nicotine stomatitis, which is keratosis in response to heat from tobacco smoking (rather than a response to the carcinogens in tobacco smoke). The risk of malignant transformation is similar to normal mucosa. Mechanical trauma, e.g. caused by a sharp edge on a denture, or a broken tooth, may cause white patches which appear very similar to leukoplakia. However, these white patches represent a normal hyperkeratotic reaction, similar to a callus on the skin, and will resolve when the cause is removed.[1] Where there is a demonstrable cause such as mechanical or thermal trauma, the term idiopathic leukoplakia should not be used.

Pathophysiology

[edit]

Tumor suppressor genes

[edit]

Tumor suppressor genes are genes involved in the regulation of normal cell turnover and apoptosis (programmed cell death).[29] One of the most studied tumor suppressor genes is p53, which is found on the short arm of chromosome 17. Mutation of p53 can disrupt its regulatory function and lead to uncontrolled cell growth.[29] Mutations of p53 have been demonstrated in the cells from areas of some leukoplakias, especially those with dysplasia and in individuals who smoke and drink heavily.[29]

DNA damage

[edit]

DNA damage was measured in oral leukoplakia patients using single cell gel electrophoresis (also called the "comet assay") applied to peripheral blood samples. The level of DNA damage was found to increase in a stepwise manner from healthy controls, through patients with non-dysplastic epithelium to patients with varying grades of dysplasia.[35] In another study, DNA damage, also measured by the comet assay, was found to be greater in oral leukoplakia and squamous-cell carcinoma than in control subjects.[36]

Diagnosis

[edit]

Definition

[edit]

Leukoplakia is a diagnosis of exclusion, meaning that which lesions are included depends upon what diagnoses are currently considered acceptable.[29] Accepted definitions of leukoplakia have changed over time and are still controversial.[30] It is possible that the definition will be further revised as new knowledge becomes available.[29] In 1984 an international symposium agreed upon the following definition: "a whitish patch or plaque, which cannot be characterized clinically or pathologically as any other disease, and is not associated with any physical or chemical agent except the use of tobacco."[29] There were, however, problems and confusion in applying this definition.[29] At a second international symposium held in 1994, it was argued that whilst tobacco was a likely causative factor in the development of leukoplakia, some white patches could be linked directly to the local effects of tobacco by virtue of their disappearance following smoking cessation, suggesting that this kind of white patch represents a reactive lesion to local tissue irritation rather than a lesion caused by carcinogens in cigarette smoke, and could be better termed to reflect this etiology, e.g. smokers' keratosis.[29] The second international symposium, therefore, revised the definition of leukoplakia to: "a predominantly white lesion of the oral mucosa that cannot be characterized as any other definable lesion."

In the mouth, the current definition of oral leukoplakia adopted by the World Health Organization is "white plaques of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer".[37] However, this definition is inconsistently applied in the medical literature, and some refer to any oral white patch as "leukoplakia".[3]

The term has been incorrectly used for white patches of any cause (rather than specifically referring to idiopathic white patches) and also to refer only to white patches which have a risk of cancerous changes.[3] It has been suggested that leukoplakia is an unhelpful term since there is so much inconsistency surrounding its use,[3] and some clinicians now avoid using it at all.[30]

Biopsy

[edit]
Microscopic examination of keratinocytes scraped from the buccal mucosa

Tissue biopsy is usually indicated[5] to rule out other causes of white patches and also to enable a detailed histologic examination to grade the presence of any epithelial dysplasia. This is an indicator of malignant potential and usually determines the management and recall interval. The sites of a leukoplakia lesion that are preferentially biopsied are the areas that show induration (hardening) and erythroplasia (redness), and erosive or ulcerated areas. These areas are more likely to show any dysplasia than homogeneous white areas.[5]

Brush biopsy/exfoliative cytology is an alternative to incisional biopsy,[5] where a stiff brush is scraped against the lining of the mouth to remove a sample of cells. This is then made into a smear which can be examined microscopically. Sometimes the biopsy site can be selected with adjunct methods which aim to highlight areas of dysplasia. Toluidine blue staining, where the dye is preferentially retained by dysplastic tissue, is sometimes used, but there is high false positive rate.[3] Other methods involve the use of luminescence, relying on either the property of normal autoflorescent molecules in mucosa such as collagen and keratin which is lost from areas of dysplasia or carcinoma under blue light or by initially staining of the mucosa with toluidine blue or dilute acetic acid and examination under white light.[3]

Histologic appearance

[edit]

Leukoplakia has a wide range of possible histologic appearances. The degree of hyperkeratosis, epithelial thickness (acanthosis/atrophy), dysplasia and inflammatory cell infiltration in the underlying lamina propria are variable.[29] In mucous membranes, hyperkeratosis can be defined as "an increase in the thickness of the keratin layer of the epithelium, or the presence of such a layer in a site where none would normally be expected."[22] In leukoplakia, the hyperkeratosis varies in thickness and may be either ortho- or para-keratosis, (depending upon whether cell nuclei are lost or retained in the superficial layers respectively), or a mixture of both in different areas of the lesion.[29][38]

The epithelium may show hypertrophy (e.g. acanthosis) or atrophy. Red areas within leukoplakia represent atrophic or immature epithelium which has lost the ability to keratinize.[1] The transition between the lesion and normal surrounding mucosa may be well-demarcated, or poorly defined. Melanin, a pigment naturally produced in oral mucosa, can leak from cells and give a grey color to some leukoplakia lesions.[29]

Hyperkeratosis and altered epithelial thickness may be the only histologic features of a leukoplakia lesion, but some show dysplasia. The word "dysplasia" generally means "abnormal growth", and specifically, in the context of oral red or white lesions, refers to microscopic changes ("cellular atypia") in the mucosa that indicate a risk of malignant transformation.[3] When dysplasia is present, there is generally an inflammatory cell infiltration in the lamina propria.[38] The following are commonly cited as being possible features of epithelial dysplasia in leukoplakia specimens:[3][29]

  • Cellular pleomorphism, in which cells are of abnormal and different shapes.
  • Nuclear atypia, in which the nuclei of cells varies in size, any may be increased in size relative to the cytoplasm, shape, and may stain more intensely. There may also be more prominent nucleoli.
  • Increased number of cells seen undergoing mitosis, including both normal and abnormal mitoses. Abnormal mitosis may be abnormally located, e.g. occurring in suprabasal cells (cell layers more superficial to the basal cell layer) or of abnormal form, e.g. "tri-radiate mitoses" (a cell splitting into 3 daughter cells rather than only 2)
  • Loss the normal organization of the epithelial layers. The distinction between the epithelial layers may be lost. Normally stratified squamous epithelium shows progressive changes in the form of cells from the basal to the superficial layers, with cells becoming more flat ("squames") towards the surface as a continuous maturation process. In dysplastic epithelium, cells may become vertically orientated rather than becoming flat towards the surface.
  • There may be abnormal keratinization, where keratin is formed below the normal keratin layer. This can occur in individual cells or groups of cells, forming an intraepithelial keratin pearl. There may be an increase in the number of basal cells, and they may lose their cellular orientation (losing their polarity and long axis).
  • Alteration of the normal epithelial-connective tissue architecture - the rete pegs may become "drop shaped". wider at their base than more superficially.

Generally, dysplasia is subjectively graded by pathologists into mild, moderate or severe dysplasia. This requires experience as it is a difficult skill to learn. It has been shown that there is high degree of inter-observer variation and poor reproducibility in how dysplasia is graded.[39] Severe dysplasia is synonymous with the term carcinoma in situ, denoting the presence of neoplastic cells which have not yet penetrated the basement membrane and invaded other tissues.

Differential diagnosis

[edit]
Cause Diagnosis
Normal anatomic variation Fordyce's spots (Fordyce's granules)
Developmental White sponge nevus
Leukoedema
Pachyonychia congenita
Dyskeratosis congenita
Tylosis
Hereditary benign intraepithelial dyskeratosis
Darier's disease (follicular keratosis)
Traumatic Frictional keratosis (e.g. morsicatio buccarum, linea alba, factitious injury)
Chemical burn
Infective Oral candidiasis
Oral hairy leukoplakia
Syphlytic leukoplakia
Immunologic Lichen planus
Lichenoid reaction (e.g. Lupus erythematosus, Graft versus host disease, Drug-induced lichenoid reaction)
Psoriasis
Idiopathic and smoking related Leukoplakia
Smoker's keratosis (Stomatitis nicotina)
Others e.g. Smokeless tobacco keratosis ("tobacco pouch keratosis")
Neoplastic Oral squamous cell carcinoma
Carcinoma in situ
Other Oral keratosis of kidney failure
Skin graft

There are many known conditions that present with a white lesion of the oral mucosa, but the majority of oral white patches have no known cause.[3] These are termed leukoplakia once other likely possibilities have been ruled out. There are also few recognized subtypes of leukoplakia, described according to the clinical appearance of the lesion.

Almost all oral white patches are usually the result of keratosis.[3] For this reason, oral white patches are sometimes generally described as keratoses, although a minority of oral white lesions are not related to hyperkeratosis, e.g. epithelial necrosis and ulceration caused by a chemical burn (see: Oral ulceration#Chemical injury).[3] In keratosis, the thickened keratin layer absorbs water from saliva in the mouth and appears white in comparison with normal mucosa. Normal oral mucosa is a red-pink color due to the underlying vasculature in the lamina propria showing through the thin layer of epithelium. Melanin produced in the oral mucosa also influences the color, with a darker appearance being created by higher levels of melanin in the tissues (associated with racial/physiologic pigmentation, or with disorders causing melanin overproduction such as Addison's disease).[29] Other endogenous pigments can be overproduced to influence the color, e.g. bilirubin in hyperbilirubinemia or hemosiderin in hemochromatosis, or exogenous pigments such as heavy metals can be introduced into the mucosa, e.g. in an amalgam tattoo.

Almost all white patches are benign, i.e. non-malignant. The differential diagnosis of a white lesion in the mouth can be considered according to a surgical sieve (see table).[3][29][40][38]

Leukoplakia cannot be rubbed off the mucosa,[14] distinguishing it readily from white patches such as pseudomembraneous candidiasis, where a white layer can be removed to reveal an erythematous, sometimes bleeding surface underneath. The white color associated with leukoedema disappears when the mucosa is stretched. A frictional keratosis will generally be adjacent to a sharp surface such as a broken tooth or rough area on a denture and will disappear when the causative factor is removed. Some have a suggested as general rule that any lesion that does not show signs of healing within 2 weeks should be biopsied.[40] Morsicatio buccarum and linea alba are located at the level of the occlusal plane (the level at which the teeth meet). A chemical burn has a clear history of placing an aspirin tablet (or other caustic substance such as eugenol) against the mucosa in an attempt to relieve toothache. Developmental white patches usually are present from birth or become apparent earlier in life, whilst leukoplakia generally affects middle aged or elderly people. Other causes of white patches generally require pathologic examination of a biopsy specimen to distinguish with certainty from leukoplakia.

Management

[edit]

A systematic review found that no treatments commonly used for leukoplakia have been shown to be effective in preventing malignant transformation. Some treatments may lead to healing of leukoplakia, but do not prevent relapse of the lesion or malignant change.[9] Regardless of the treatment used, a diagnosis of leukoplakia almost always leads to a recommendation that possible causative factors such as smoking and alcohol consumption be stopped,[40] and also involves long term review of the lesion,[40] to detect any malignant change early and thereby improve the prognosis significantly.

Predisposing factors and review

[edit]

Beyond advising smoking cessation, many clinicians will employ watchful waiting rather than intervene. Recommended recall intervals vary. One suggested program is every 3 months initially, and if there is no change in the lesion, then annual recall thereafter. Some clinicians use clinical photographs of the lesion to help demonstrate any changes between visits. Watchful waiting does not rule out the possibility of repeated biopsies.[3] If the lesion changes in appearance repeat biopsies are especially indicated.[2] Since smoking and alcohol consumption also places individuals at higher risk of tumors occurring in the respiratory tract and pharynx, "red flag" symptoms (e.g. hemoptysis - coughing blood) often trigger medical investigation by other specialties.[3]

Surgery

[edit]

Surgical removal of the lesion is the first choice of treatment for many clinicians. However, the efficacy of this treatment modality cannot be assessed due to insufficient available evidence.[9] This can be carried out by traditional surgical excision with a scalpel, with lasers, or with eletrocautery or cryotherapy.[40] Often, if biopsy demonstrates moderate or severe dysplasia then the decision to excise them is taken more readily. Sometimes, white patches are too large to remove completely and instead they are monitored closely. Even if the lesion is completely removed, long term review is still usually indicated since leukoplakia can recur, especially if predisposing factors such as smoking are not stopped.[2]

Medications

[edit]

Many different topical and systemic medications have been studied, including anti-inflammatories, antimycotics (target Candida species), carotenoids (precursors to vitamin A, e.g. beta carotene), retinoids (drugs similar to vitamin A), and cytotoxics, but none have evidence that they prevent malignant transformation in an area of leukoplakia.[9] Vitamins C and E have also been studied with regards a therapy for leukoplakia.[2] Some of this research is carried out based upon the hypothesis that antioxidant nutrients, vitamins and cell growth suppressor proteins (e.g. p53) are antagonistic to oncogenesis.[2] High doses of retinoids may cause toxic effects.[9] Other treatments that have been studied include photodynamic therapy.[9]

Prognosis

[edit]
White patch on left buccal mucosa. Biopsy showed early squamous cell carcinoma. The lesion is suspicious because of the presence of nodules
Nodular leukoplakia in right commissure. Biopsy showed severe dysplasia

The annual malignant transformation rate of leukoplakia rarely exceeds 1%,[9] i.e. the vast majority of oral leukoplakia lesions will remain benign.[32] A number of clinical and histopathologic features are associated with varying degrees of increased risk of malignant transformation, although other sources argue that there are no universally accepted and validated factors which can reliably predict malignant change.[32] It is also unpredictable to an extent if an area of leukoplakia will disappear, shrink or remain stable.[41]

  • Presence and degree of dysplasia (mild, moderate or severe/carcinoma in situ). While the degree of dysplasia has been shown to be an important predictor of malignant change,[3] many have challenged its use due to the low predictive value from the lack of objectivity of grading dysplasia.[42][43][44] While 10% of leukoplakia lesions show dysplasia when biopsied,[9] as many as 18% of oral lesions undergo malignant change in the absence of dysplasia.[45]
  • Leukoplakia located on the floor of the mouth, the posterior and lateral tongue, and the retromolar areas (the region behind the wisdom teeth) have higher risk, whereas white patches in areas such as the top surface of the tongue and the hard palate do not have significant risk.[3] Although these "high risk" sites are recognized, statistically, leukoplakia is more common on the buccal mucosa, alveolar mucosa, and the lower labial mucosa.[30] Leukoplakia of the floor of the mouth and tongue accounts for over 90% of leukoplakias showing dysplasia or carcinoma on biopsy.[2] This is thought to be due to pooling of saliva in the lower part of the mouth, exposing these areas to more carcinogens held in suspension.
  • Red lesions (erythroplasia) and mixed red and white lesions (erythroleukoplakia/"speckled leukoplakia") have a higher risk of malignant change than homogeneous leukoplakia.[15]
  • Verrucous or nodular areas have a higher risk.[3]
  • Although smoking increases risk of malignant transformation, smoking also causes many white patches with no dysplasia.[3] This means that statistically, white patches in non-smokers have a higher risk.[2]
  • Older people with white patches are at higher risk.[3]
  • Larger white patches are more likely to undergo malignant transformation than smaller lesions.[3]
  • White patches which have been present for a long period of time have a higher risk.[3]
  • Persons with a positive family history of cancer in the mouth.[3]
  • Candida infection in the presence of dysplasia has a small increased risk.[3]
  • A change in the appearance of the white patch, apart from a change in the color, has a higher risk.[3] Changes in the lesion such as becoming fixed to underlying tissues, ulceration, cervical lymphadenopathy (enlargement of lymph nodes in the neck), and bone destruction may herald the appearance of malignancy.[29]
  • White patches present in combination with other conditions that carry a higher risk (e.g. oral submucous fibrosis), are more likely to turn malignant.[3]
  • Although overall, oral cancer is more common in males, females with white patches are at higher risk than men.[3]

Epidemiology

[edit]

The prevalence of oral leukoplakia varies around the world, but generally speaking it is not an uncommon condition.[9] Reported prevalence estimates range from less than 1% to more than 5% in the general population.[9] Leukoplakia is, therefore, the most common premalignant lesion that occurs in the mouth.[41] Leukoplakia is more common in middle-aged and elderly males.[30] The prevalence increases with increasing age.[2] In areas of the world where smokeless tobacco use is common, there is a higher prevalence.[2] In the Middle East region, the prevalence of leukoplakia is less than 1% (0.48%).[46]

Etymology

[edit]

The word leukoplakia means "white patch",[3] and is derived from the Greek words λευκός - "white" and πλάξ - "plate".[47]

History

[edit]

The term leukoplakia was coined in 1861 by Karl Freiherr von Rokitansky, who used it to refer to white lesions of the urinary tract.[26] In 1877, Schwimmer first used the term for an oral white lesion.[30] It is now thought that this white lesion on the tongue represented syphilitic glossitis,[30] a condition not included in the modern definitions of oral leukoplakia. Since then, the word leukoplakia has been incorporated into the names for several other oral lesions (e.g. candidal leukoplakia, now more usually termed hyperplastic candidiasis).[3] In 1930, it was shown experimentally that leukoplakia could be induced in rabbits that were subjected to tobacco smoke for 3 minutes per day.[48] According to one source from 1961, leukoplakia can occur on multiple different mucous membranes of the body, including in the urinary tract, rectum, vagina, uterus, vulva, paranasal sinuses, gallbladder, esophagus, eardrums, and pharynx.[26] Generally, oral leukoplakia is the only context where the term is in common usage in modern medicine. In 1988, a case report used the term acquired dyskeratotic leukoplakia to refer to an acquired condition in a female where dyskeratotic cells were present in the epithelia of the mouth and genitalia.[49]: 480 [31]: 806 

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Leukoplakia is a clinical condition defined as a predominantly or plaque on the that cannot be characterized clinically or pathologically as any other definable disease, often appearing as thick, or grayish patches on the mucous membranes of the oral cavity, including the , gums, inside of the cheeks, or floor of the mouth, which cannot be easily scraped off and are typically painless. These lesions are considered potentially malignant disorders (OPMDs), with a subset serving as precancerous changes that may progress to oral , though most cases remain benign. The condition is multifactorial in origin, strongly linked to chronic irritation and exposure to carcinogens such as , and affects approximately 2.6% of the global population, predominantly middle-aged and older adults. Proliferative verrucous leukoplakia (PVL) is a rare, aggressive subtype with a high risk of exceeding 60%. Oral , often confused with leukoplakia, is a separate condition associated with Epstein-Barr virus in immunocompromised individuals and is not precancerous.

Definition and Overview

Leukoplakia is a clinical term referring to a predominantly white patch or plaque on the mucous membranes that cannot be characterized clinically or pathologically as any other definable lesion. According to the World Health Organization (WHO), it is specifically defined as "a white plaque of questionable risk having excluded other known diseases or disorders that carry no increased risk for cancer." This definition emphasizes the exclusionary nature of the diagnosis, requiring that the lesion persists and is not attributable to identifiable causes such as infection or trauma. The condition is distinguished from reversible or pseudomembranous white lesions, such as those caused by , which can often be scraped off, or frictional keratoses and smokers' lesions that may resolve upon removal of the irritant. Historical WHO criteria from 1978 described it as "a white patch or plaque that cannot be characterized clinically or pathologically as any other ," with later refinements in 1997 and 2005 incorporating the aspect of malignancy risk. To confirm persistence, clinical observation for 4-8 weeks after addressing potential reversible factors is recommended before diagnosing leukoplakia. While leukoplakia most commonly occurs in the oral cavity, particularly on the or of the , it can rarely appear on other mucous membranes such as the genital or laryngeal regions.

Epidemiology

Leukoplakia, particularly oral leukoplakia (OLK), exhibits a global ranging from approximately 1% to 5% in the general population, with pooled estimates from systematic reviews indicating an overall rate of 3.41% (95% CI: 2.65–4.26%) based on data from 1996 to 2022 across 69 studies involving over 1.2 million participants. In population-based studies, the prevalence is around 2.23%, while clinic-based assessments report 1.36%, and rates in high-risk groups, such as smokers, can reach 9.10% or higher, up to 9.48% among users. These figures underscore the condition's variability depending on study design and population selection. Demographically, OLK predominantly affects males, with prevalence rates 1.8 to 3.9 times higher than in females; for instance, population-based studies show 5.86% in males versus 1.50% in females. The condition is more common in adults over 40 years, peaking in the 41–60 age group (up to 46.6% of cases), and continuing to rise with age, reaching 2.21% in those over 60. Certain ethnic groups in South Asia exhibit elevated rates, largely attributable to cultural practices like combined with . Geographically, prevalence varies significantly, with higher rates in (2.53% population-based, 12.77% in specific high-risk groups) compared to (1.82% population-based, 4.85% in high-risk groups), (0.33% population-based), (1.15% population-based), (2.43% population-based), and (11.74% population-based). In tobacco- and betel-heavy regions like and , rates can exceed 3% in general populations and up to 23% in localized studies, driven by prevalent use. Temporal trends indicate relative stability in global from 1996 to 2022, with no significant changes across regions or diagnostic definitions. However, cohort studies demonstrate that cessation can substantially reduce incidence, with one 10-year follow-up showing a marked decline in new cases following quitting, suggesting potential decreases in high-risk areas amid ongoing anti- campaigns as of 2025.

Classification

Oral Leukoplakia

Oral leukoplakia represents the primary manifestation of leukoplakia, accounting for over 90% of all cases, as extraoral occurrences are uncommon and often designated by site-specific terminology. It is defined clinically as a predominantly white plaque of questionable risk on the , having excluded other known diseases or disorders that carry no increased risk for cancer. The condition predominantly affects adults over 40 years, with a higher incidence in males, and exhibits a global ranging from 1% to 4% in the general , influenced by use and regional variations. The (WHO) classifies oral leukoplakia into two main categories: homogeneous and non-homogeneous, based on clinical appearance, to facilitate risk assessment for . Homogeneous leukoplakia presents as uniform, flat, white patches with a smooth, thin, or slightly wrinkled surface, often on the buccal mucosa, gingiva, or ; these lesions are generally associated with lower malignant potential, though persistent cases warrant monitoring. In contrast, non-homogeneous leukoplakia includes speckled, nodular, or verrucous forms, characterized by irregular, raised, or mixed red-and-white surfaces that indicate and carry a significantly higher risk of progression to , with transformation rates up to 15-20% in high-risk variants. Specific subtypes further delineate oral leukoplakia based on morphology, location, and etiology. Sublingual keratosis, a form of homogeneous leukoplakia, appears as diffuse, whitish changes on the floor of the mouth, ventral tongue, and lingual mucosa; this subtype is particularly high-risk due to its anatomic site, with malignant transformation rates reported as high as 10-15%. Candidal leukoplakia, also known as chronic hyperplastic candidosis, manifests as adherent, raised white plaques often on the commissures or dorsal tongue, associated with persistent Candida albicans infection and epithelial hyperplasia; it responds to antifungal therapy but requires biopsy to rule out dysplasia. Proliferative verrucous leukoplakia, a distinctive non-homogeneous variant under WHO criteria, is a progressive, multifocal condition with warty or verrucous white plaques, frequently involving the gingiva and progressing slowly over years; it exhibits an aggressive behavior with malignant transformation in up to 70% of cases, necessitating vigilant surveillance. Syphilitic leukoplakia, a rare subtype tied to tertiary syphilis from Treponema pallidum infection, presents as extensive, homogenous white patches covering large mucosal areas, historically linked to higher cancer risk due to past treatments but now managed with antibiotics; its clinical relevance lies in prompting serological testing for syphilis. Risk stratification emphasizes non-homogeneous features, high-risk sites like the floor of the mouth, and subtypes such as proliferative verrucous or sublingual keratosis, guiding biopsy and follow-up protocols to detect dysplasia early.

Leukoplakia in Other Sites

Leukoplakia occurring outside the oral cavity is rare, representing less than 5% of all reported cases, with the majority of documented instances limited to the , genitourinary tract, and gastrointestinal sites such as the . These extraoral manifestations often arise from site-specific chronic irritations and lack the standardized systems applied to oral forms, leading to challenges in early detection and potentially worse due to delayed . Unlike oral leukoplakia, which is frequently linked to use, extraoral variants show variable associations with local factors like or , and they are typically identified incidentally during endoscopic or imaging procedures. Esophageal leukoplakia, also known as esophageal epidermoid , presents as superficially raised, scaly white plaques with clear borders on , often exhibiting a appearance in the mid-esophagus or above the squamocolumnar junction. Its is low, reported at 0.19% among patients undergoing esophageal biopsies and observed in only 6 per 1,000 cases. The condition is proposed to result from chronic irritation, including , alongside tobacco and alcohol exposure, though human papillomavirus association is absent, differing from some oral cases. Due to its potential as a precursor to , endoscopic is recommended, highlighting its rarer occurrence and female predominance compared to oral leukoplakia. In genitourinary sites, leukoplakia manifests as keratinizing , particularly in the where it appears as whitish or pigmented plaques amid inflamed mucosa, with an incidence of approximately 1 in 10,000 cases. involvement is strongly linked to chronic irritation from bacterial infections, neurogenic conditions, long-term catheterization, or outlet obstruction, presenting with nonspecific symptoms like , , and . Diagnosis requires to distinguish it from mimics such as malakoplakia or fungal cystitis, but surveillance via is challenging due to keratin overlay obscuring underlying , and it carries a risk of progression to , necessitating annual monitoring. Vulvar and vaginal leukoplakia is exceedingly rare, often encompassing conditions like or squamous cell hyperplasia rather than a distinct entity, although often benign, it carries a risk of progression to dysplasia or squamous cell carcinoma (approximately 2-7%), so medical evaluation including biopsy is recommended to confirm diagnosis and rule out malignancy, with a of 1 in 300 to 1,000 women, predominantly postmenopausal, and sometimes overlapping with in inflammatory variants. These lesions appear as white patches and are managed conservatively with topical corticosteroids, though their low prevalence complicates standardized classification. In the and other gastrointestinal sites, leukoplakia presents as rare white, verrucous plaques, potentially arising from frictional trauma or , though direct HPV linkage is less established than in oral or cervical sites. Such patches are infrequently reported, often detected during in the context of chronic irritation or , and exhibit a 10-20% risk of dysplastic progression, underscoring detection difficulties in non-routine screening areas. Overall, extraoral leukoplakia features less uniform diagnostic criteria than its oral counterpart, with poorer outcomes in sites like the and attributable to anatomical barriers to visualization and , emphasizing the need for site-tailored endoscopic approaches.

Clinical Features

Signs and Symptoms

Leukoplakia primarily manifests as adherent white or grayish patches or plaques on the mucous membranes, which cannot be scraped off and may vary in texture from smooth and flat to rough, wrinkled, ridged, or ulcerated. These lesions are often irregular in shape and slightly raised, appearing homogeneous in lower-risk forms or speckled with red areas in more concerning variants. The condition is frequently , with many patients unaware of the patches until detected during routine examination, though some experience mild discomfort, burning sensation, or upon contact with food or , particularly in oral sites like the buccal mucosa. In advanced cases, symptoms may progress to include pain, restricted mouth opening (), or due to involvement of deeper tissues. Homogeneous leukoplakia tends to be less symptomatic compared to non-homogeneous subtypes. Indicators of potential progression include thickening or induration (hardening) of the patches, development of lumps, or admixture with (red patches), which signal a higher risk of . Persistent sores or changes lasting beyond two weeks further warrant attention. Site-specific variations occur, such as and discomfort in oral leukoplakia affecting the buccal mucosa, while esophageal leukoplakia is often but may cause (difficulty swallowing) or a globus sensation (feeling of a lump in the ) if symptomatic.

Sites of Involvement

Leukoplakia most commonly manifests in the oral cavity, where it affects various mucosal surfaces with distinct patterns of distribution and . High-risk sites for include the floor of the mouth, ventral surface of the , and , where lesions are more likely to exhibit due to their anatomical vulnerability to chronic . In contrast, lower- areas such as the buccal mucosa, gingiva, and mandibular sulcus are more frequent sites of occurrence but carry a reduced potential for progression to . The buccal mucosa and gingiva are among the most prevalent locations, with reported rates varying by study (buccal mucosa 19.5–40.4%, gingiva up to 34.6%, 22.8–36.4%), while the floor of the mouth is less common but higher . Extra-oral involvement is less common but occurs in squamous or transitional epithelia of other mucosal sites. In the , leukoplakia typically appears in the mid-to-distal regions, often as white plaques near or above the squamocolumnar junction, and is associated with conditions like achalasia or chronic inflammation. Bladder leukoplakia, characterized by keratinizing , predominantly affects the trigone area, comprising about 78% of cases, and is linked to recurrent infections or irritation. Lesions in the are localized to the squamous zone or transition area near the dentate line, presenting as asymptomatic white plaques that may relate to chronic trauma or human papillomavirus exposure. Genital sites, including the , , and , harbor rare occurrences, often as hyperkeratotic patches in response to local irritants or infections, with vulvar involvement being the most reported. Leukoplakia often exhibits multifocal patterns, particularly in the oral cavity, where lesions may spread across multiple subsites influenced by shared risk factors like tobacco exposure. Extra-oral manifestations are frequently and discovered incidentally during procedures such as for esophageal evaluation or for assessment, highlighting the importance of targeted in at-risk populations.

Causes and Risk Factors

Tobacco and Alcohol Use

Tobacco use, particularly in smoked and smokeless forms, is a primary risk factor for leukoplakia, with epidemiological studies indicating that approximately 80% of cases are associated with tobacco consumption habits. Smoked tobacco, such as cigarettes, exposes the oral mucosa to carcinogens including tobacco-specific nitrosamines (TSNAs) like N'-nitrosonornicotine, which contribute to mucosal damage through chronic irritation and inflammation. The relative risk of developing oral leukoplakia among smokers is elevated 5- to 9-fold compared to non-smokers, with risks reaching 9- to 15-fold for heavier use, such as more than 10 cigarettes per day. Smokeless tobacco products, including snuff and , pose risks through direct contact with the , leading to localized lesions via TSNAs and other carcinogens that induce keratinization and . The for leukoplakia from use is approximately 3-fold, though it increases significantly when combined with , where odds ratios exceed 10-fold. A clear dose-response relationship exists, with risk escalating based on duration and intensity of use; for instance, prolonged exposure to higher amounts of shows stronger associations with lesion development. Alcohol consumption independently elevates leukoplakia risk through chronic mucosal irritation and its role as a tumor promoter, with rates of 5.7% among regular users compared to 2.9% in non-users. It exhibits a synergistic effect with , enhancing penetration into the mucosa and amplifying overall risk up to 14-fold when combined with . Cessation of use can reverse leukoplakia risk, with studies showing substantial reduction in incidence and up to 97.5% clinical resolution within weeks of quitting.

Other Etiological Factors

Chronic mechanical from sources such as ill-fitting , sharp or fractured teeth, and faulty dental restorations can contribute to the development of leukoplakia by inducing persistent trauma to the . This type of irritation promotes as a protective response, potentially leading to white plaque formation, particularly in areas of repeated contact. Chemical exposures, including the practice of holding aspirin tablets against the mucosa for pain relief, may also cause localized chemical burns that manifest as leukoplakia-like lesions. Infectious agents play a role in specific subtypes of leukoplakia. Candidal leukoplakia, often associated with infection, presents as a non-homogeneous white plaque, typically on the , and is characterized by hyperplastic ; this form may exhibit higher malignant potential due to chronic inflammation and nitrosation. Human papillomavirus (HPV), particularly high-risk types like HPV-16, has been detected in some oral leukoplakia cases, though evidence for a direct causal role remains limited and controversial. can rarely produce leukoplakia-like lesions, such as syphilitic leukoplakia on the dorsum, as part of secondary syphilis manifestations. Other etiological factors include (UV) radiation exposure, which is implicated in leukoplakia of the vermilion, akin to , due to cumulative photodamage in sun-exposed areas. Use of oral care products containing extract, such as certain toothpastes and mouthwashes (e.g., Viadent), has been linked to a specific form of leukoplakia, often on the maxillary vestibule or , with lesions resolving upon discontinuation. Epithelial associated with , resulting from deficiency, may predispose women to mucosal changes resembling leukoplakia, as observed in case reports where led to lesion resolution. quid chewing without is also a significant risk factor, particularly in regions like , with current use associated with increased odds of leukoplakia development. A substantial proportion of leukoplakia cases, particularly in non-smokers, are considered idiopathic, lacking identifiable risk factors beyond multifactorial influences.

Pathophysiology

Cellular and Molecular Mechanisms

Leukoplakia is characterized at the cellular level by , the excessive thickening of the layer in the , and acanthosis, the thickening of the prickle cell layer, both resulting from chronic that stimulates prolonged epithelial proliferation. These changes arise as respond to persistent stimuli by increasing differentiation and production, leading to the formation of white plaques. The hyperproliferative state is driven by overexpression of growth factors such as (EGFR), which promotes uncontrolled in the basal layers. An associated inflammatory response further exacerbates these alterations through the release of proinflammatory s, including interleukin-6 (IL-6) and tumor factor-alpha (TNF-α), which create a pro-oncogenic microenvironment. Elevated IL-6 levels in leukoplakia lesions correlate with increased epithelial proliferation and severity, as this activates signaling pathways that enhance cell survival and growth. Similarly, TNF-α contributes to chronic inflammation by recruiting immune cells and promoting tissue remodeling, thereby sustaining the hyperplastic . This inflammatory milieu can trigger DNA damage as an initial event, setting the stage for further pathological changes. Field cancerization manifests as multifocal cellular changes across the surrounding , where shared exposures lead to clonal expansion of altered within a precancerized epithelial field. These fields consist of cytogenetically unstable cells that progressively replace normal through replicative advantage, increasing the risk of leukoplakia development and . The process involves widespread accumulation of proliferative signals, enabling synchronous lesions from a common population. Epithelial-mesenchymal transition (EMT) plays a critical role in leukoplakia progression by enabling epithelial cells to acquire mesenchymal traits, such as enhanced motility and invasiveness. This transition is marked by downregulation of E-cadherin, which disrupts cell-cell adhesion and activates pathways like Wnt/β-catenin, facilitating early tumor . Overexpression of markers like podoplanin during EMT further promotes cellular migration, linking hyperkeratotic lesions to potential .

Genetic and DNA Alterations

Leukoplakia is characterized by various genetic alterations that contribute to its development and potential progression to , with in tumor suppressor genes playing a central role. in the TP53 gene, which encodes the protein, occur frequently in oral leukoplakia lesions, with immunohistochemical studies showing overexpression in approximately 70% of cases, often indicating underlying genetic dysfunction leading to impaired regulation and increased genomic instability. These alterations disrupt and mechanisms, facilitating the accumulation of further in premalignant cells. DNA damage in leukoplakia is prominently driven by induced by environmental carcinogens such as those in tobacco smoke, resulting in the formation of DNA adducts and subsequent genomic instability. This oxidative damage can lead to (MSI), a hallmark of defective , observed in a subset of oral premalignant lesions including leukoplakia. Such changes promote error-prone replication and clonal expansion of mutated cells. Oncogene activation further exacerbates leukoplakia progression, notably through overexpression of (CCND1), reported in about 30% of cases, which accelerates the G1/ transition and uncontrolled proliferation. Additionally, (LOH) at the 9p21 locus, affecting the gene encoding the tumor suppressor, is detected in up to 51% of leukoplakia samples, correlating with higher risk of by inactivating . Epigenetic modifications, particularly hyper of promoter regions in tumor suppressor genes, are enriched in high-risk leukoplakia lesions and contribute to without altering the DNA sequence. Aberrant patterns in multiple genes, such as those involved in and pathways, are associated with dysplastic features and increased malignant potential in these premalignant conditions.

Diagnosis

Clinical Assessment

Clinical assessment of leukoplakia begins with a comprehensive to evaluate the lesion's characteristics and associated risk factors. Clinicians should inquire about the duration of the white patch, which is often but may involve reports of gradual growth, color changes, or associated discomfort. A detailed is essential, focusing on use (both smoked and smokeless forms), alcohol consumption, , and other irritants like ill-fitting or sharp teeth, as these are primary modifiable risk factors strongly linked to development. Additionally, documenting any progression, such as increasing size or surface irregularity, helps gauge potential urgency, while noting patient demographics like age over 50 or female gender, which correlate with higher risk subtypes. Physical examination follows, emphasizing conventional visual and tactile evaluation of the oral cavity. identifies the lesion's appearance, distinguishing homogeneous (uniform white plaques with lower risk) from non-homogeneous types (speckled, nodular, or verrucous with elevated malignant potential), alongside assessing size, borders, and location—high-risk sites include the floor of the mouth and ventral . is critical to detect induration or hardness at the lesion's periphery, which signals increased risk, as well as texture (e.g., flat versus exophytic) and mobility, ensuring the patch cannot be scraped off to differentiate from pseudomembranous conditions. This intraoral and extraoral exam should be systematic, using good lighting and retraction to avoid missing multifocal lesions. Adjunctive techniques may enhance identification of high-risk areas during assessment. Vital staining with toluidine blue, applied topically, selectively highlights dysplastic or malignant by binding to nucleic acids, aiding in delineating suspicious regions for closer monitoring, though it is not recommended for routine use due to variable specificity (around 70-80%). Autofluorescence devices, which detect tissue loss in abnormal areas under blue light, offer another non-invasive option for visualizing extent, but evidence supports their conditional application only for suspicious cases, with sensitivity near 90%. Imaging plays a limited role in initial clinical assessment, primarily to evaluate lesion extent in specific oral sites. may be employed for floor-of-mouth or posterior lesions to assess bony involvement or adjacent structures, particularly if suggests deeper extension. For extra-oral leukoplakia, such as in laryngeal or genital sites, provides direct visualization, though this is less common in standard oral evaluations. Risk stratification relies on clinical features to prioritize follow-up, as no universally standardized scoring system exists; instead, composite assessment considers site (e.g., floor of as high-risk locus), appearance (non-homogeneous conferring 4-10 times higher transformation risk), size exceeding 200 mm², and patient factors like non-smoker status or lesion duration over two years. Lesions in high-risk loci or with induration warrant more frequent surveillance, while low-risk homogeneous plaques on low-risk sites (e.g., buccal mucosa) may be monitored less intensively.

Histopathological Examination

Histopathological examination via biopsy is essential for confirming the diagnosis of leukoplakia and assessing its malignant potential. Incisional biopsy serves as the gold standard, particularly for suspicious or persistent lesions, and is recommended when complete excision is not feasible; it involves removing a representative sample from the lesion's edge and center to capture the most atypical areas. For multifocal or extensive lesions, multiple incisional biopsies from different sites may be necessary to evaluate heterogeneity and guide risk stratification. Excisional biopsy, performed with a scalpel or laser (such as CO2 laser), is preferred for smaller lesions, as it allows for complete removal and margin assessment while providing adequate tissue for analysis. Laser excision offers advantages in hemostasis and reduced postoperative pain but must ensure sufficient tissue depth for histopathological evaluation. The hallmark histologic criteria for leukoplakia include (orthokeratotic or parakeratotic) and , typically confined to the surface without invasion of the underlying . These features reflect a reactive or premalignant process, often accompanied by acanthosis and a thickened spinous layer, but the absence of distinguishes benign from higher-risk variants. When present, dysplastic changes—such as architectural disturbances (e.g., irregular stratification, bulbous rete ridges, and loss of polarity) and cytological (e.g., enlarged hyperchromatic nuclei, increased nuclear-cytoplasmic ratio, and abnormal mitoses)—indicate potential progression and are observed in 19-46% of leukoplakia cases. Tissue processing involves formalin fixation, paraffin embedding, and sectioning at 4-5 μm thickness, followed by hematoxylin and (H&E) staining for routine microscopic evaluation. Dysplasia grading in leukoplakia follows the World Health Organization (WHO) classification (5th edition, 2020), which employs a three-tier system—mild, moderate, and severe—based on the extent and severity of architectural and cytological atypia across the epithelial layers. Mild dysplasia involves limited changes confined to the lower third of the epithelium, such as slight irregularity in stratification and minimal cytological atypia; moderate dysplasia affects up to two-thirds of the thickness with more pronounced features like drop-shaped rete ridges and increased mitoses; severe dysplasia extends through the full thickness, incorporating carcinoma in situ, with marked loss of cohesion, abnormal superficial mitoses, and severe nuclear pleomorphism. This system emphasizes a semi-quantitative assessment of 13 specific criteria (eight architectural and five cytological), with higher grades correlating to increased malignant transformation risk, though interobserver variability remains a challenge, sometimes addressed by adjunct binary grading (low- vs. high-grade). The presence of differentiated dysplasia, characterized by bulbous rete ridges with basaloid cells and abrupt keratinization, may be underrecognized in routine WHO grading and warrants careful scrutiny for aggressive behavior. Special stains enhance detection of associated etiological factors in leukoplakia subtypes. Periodic acid-Schiff (PAS) staining is routinely used to identify fungal hyphae of Candida species in suspected candidal leukoplakia, revealing magenta-colored structures invading the parakeratin layer. For verrucous or proliferative leukoplakia variants, in situ hybridization or polymerase chain reaction-based assays on biopsy tissue can detect human papillomavirus (HPV) DNA, particularly high-risk types like HPV-16/18, which may contribute to dysplastic progression. These ancillary techniques are applied selectively when clinical features suggest infection, aiding in subtype classification without altering the core H&E-based diagnosis.

Differential Diagnosis

Leukoplakia, characterized by white plaques in the that cannot be scraped off and are not attributable to any other disease, requires careful differentiation from other white lesions to exclude benign, precancerous, or malignant conditions. Misdiagnosis can delay appropriate , particularly given leukoplakia's potential for . Benign mimics include frictional keratosis, which presents as white plaques from chronic mechanical irritation such as cheek biting or ill-fitting dentures and typically resolves upon removal of the irritant. manifests as reticular white lines or lacy patterns, often accompanied by pain or erosions, and is associated with autoimmune processes. appears as scrapable white plaques that may reveal an erythematous base upon removal, commonly linked to or use. Precancerous conditions to consider are , featuring red, velvety patches with a higher risk of progression to malignancy than leukoplakia, and , which involves white or scaly patches on the due to chronic sun exposure. Malignant mimics primarily involve , which may present as indurated, ulcerated, or nonhomogeneous white-red lesions requiring urgent to confirm invasion. In site-specific contexts, esophageal leukoplakia, a rare epidermal , must be differentiated from benign acanthosis, which forms small, white, plaque-like elevations without malignant potential. In the bladder, leukoplakia-like differs from urothelial , a flat precancerous lesion, through showing keratinization without atypia in the former. Diagnostic clues rely on patient history (e.g., use, irritants, or ), clinical examination (e.g., scrapability of lesions), and confirmatory , which reveals without in benign cases versus atypical features in precancerous or malignant ones.

Management

Prevention and Surveillance

Primary prevention of leukoplakia focuses on eliminating modifiable risk factors, particularly through and alcohol cessation programs. Studies have demonstrated that quitting use significantly reduces the incidence of leukoplakia, with lesions often regressing or disappearing within 8-12 months of cessation. Comprehensive counseling during initial consultations, including and referrals to rehabilitation programs, is recommended to support cessation of , alcohol, and quid use. Avoiding irritants such as (areca nut) is crucial, as its use is strongly associated with leukoplakia development, and community-based education programs can address cultural barriers to discontinuation. education, including regular dental cleanings to prevent chronic mucosal trauma from , further supports prevention efforts. Secondary surveillance involves regular monitoring of existing lesions to detect progression early. For patients with nondysplastic leukoplakia, follow-up clinical examinations are advised every 6 months, while those with moderate or severe require evaluations every 3 months, continuing for at least 5 years. High-risk cases, such as those with advanced clinical features or persistent s, warrant more frequent monitoring every 3 months regardless of dysplasia grade. mapping, photography, and patient self-monitoring for changes in size, color, or texture are essential tools to track stability or evolution during these visits. Chemoprevention trials have explored agents like retinoids and antioxidants in high-risk populations, including those post-tobacco cessation, to induce lesion regression. Systemic retinoids, such as , achieved complete remission in 57.1% of cases compared to 3% with in a 6-month trial. Topical isotretinoin yielded 85% remission without over 10 years of follow-up. Antioxidants like showed 80% remission at 8 mg daily versus 12.5% placebo in a 2-month study, while dried black raspberries topically resulted in 76% remission. These interventions are considered adjunctive for high-risk lesions but require further long-term studies due to variable efficacy and potential side effects. Guidelines from authoritative bodies emphasize screening and prevention in at-risk groups. The recommends comprehensive visual and tactile examinations of the oral cavity for all adult patients during routine visits to identify potentially malignant disorders like leukoplakia early. The advocates for awareness campaigns and cessation workshops targeting tobacco and betel nut users in high-prevalence regions to prevent oral lesions.

Therapeutic Interventions

Therapeutic interventions for leukoplakia are tailored to the 's subtype, size, location, and degree of , with the goal of resolution and reduction. Surgical approaches are often preferred for dysplastic or high-risk lesions, while therapies target specific etiologies such as infections. Emerging options show but require further validation, and site-specific methods address non-oral presentations. Surgical excision remains a primary modality for localized leukoplakia, particularly when is present, involving complete removal of the with adequate margins using or to minimize recurrence. , commonly with CO2 or lasers, offers precise of tissue with reduced postoperative pain and swelling compared to traditional excision, achieving clinical resolution in over 70% of cases in short-term follow-up. , using to freeze and destroy abnormal tissue, is effective for smaller, superficial lesions and demonstrates comparable healing outcomes to laser methods, with minimal scarring. (), involving photosensitizer application followed by light activation, provides an alternative to excision for non-invasive , yielding resolution rates exceeding 50% in multiple studies. Among laser types, Er:YAG and lasers have shown lower recurrence rates than conventional , with meta-analyses indicating up to 20% reduction in for laser-based techniques. Medical treatments are subtype-specific; for candidal leukoplakia, topical or systemic antifungals such as or nystatin effectively resolve lesions by eradicating underlying Candida infection. Oral , associated with Epstein-Barr virus, responds to antiviral agents like high-dose acyclovir (up to 4000 mg daily) or valacyclovir, leading to lesion regression in most patients, though recurrence may occur upon discontinuation. Topical retinoids, including , promote epithelial differentiation and have been used for homogeneous leukoplakia, showing partial to complete response in clinical trials. Emerging interventions include supplements like beta-carotene and , which exhibit mixed evidence for regression, with some reviews reporting over 50% clinical improvement but inconsistent long-term efficacy due to variable trial designs. For high-risk forms of leukoplakia, such as proliferative verrucous leukoplakia, such as PD-1 inhibitors (e.g., nivolumab) is under investigation, demonstrating histopathological regression in some patients in phase II trials. Post-treatment is recommended to detect early recurrence or progression. Site-specific approaches for esophageal leukoplakia involve endoscopic submucosal dissection (ESD) or ablation techniques like and , which safely remove multifocal plaques with low complication rates. In anal leukoplakia, minimally invasive options such as infrared coagulation or preserve function while addressing premalignant changes, particularly in HPV-associated cases.

Prognosis

Risk of Malignancy

Leukoplakia carries a variable of malignant transformation to oral , with overall rates reported in meta-analyses ranging from 1% to 20% over a 10-year period. This transformation is notably higher in non-homogeneous lesions and those exhibiting , where rates can reach up to 50% in high-risk cases. The annual transformation rate is estimated at approximately 1-2%, though it varies by study population and lesion characteristics. Several clinical features elevate the malignant potential of leukoplakia. Lesions larger than 200 mm² are associated with a significantly increased , with one study reporting a 5.4-fold higher likelihood of progression compared to smaller lesions. Location plays a critical role, as leukoplakia on the floor of the mouth or ventral and lateral tongue demonstrates heightened transformation due to anatomical and environmental factors. Furthermore, the presence of moderate to severe markedly amplifies this , conferring up to a 4.57-fold increase in transformation probability. The progression from leukoplakia to typically occurs over several years, with median times reported between 4 and 7 years in longitudinal studies. For instance, one found a median interval of approximately 53 months from to . Recent advancements up to 2025 have highlighted molecular markers, such as (LOH) at key chromosomal loci like 3p14 and 9p21, as robust predictors of , outperforming clinical features alone in risk stratification models. These genetic alterations, including LOH profiles, enable more precise identification of high-risk lesions for targeted surveillance.

Prognostic Factors

Prognostic factors for oral leukoplakia encompass clinical characteristics, histopathological findings, and patient-related variables that influence outcomes such as persistence, recurrence, and regression, independent of malignant transformation risk. Favorable factors include regression, which occurs in approximately 30% of cases over 10 years, with higher rates (up to 90-100%) following cessation of use, particularly smokeless forms. While small lesion size is associated with lower malignant transformation risk, evidence does not consistently link size to persistence or recurrence rates. Similarly, homogeneous leukoplakia, characterized by uniform white plaques without surface irregularities, correlates with higher rates of resolution compared to non-homogeneous variants. Unfavorable prognostic indicators include multifocality, where multiple lesions increase the likelihood of persistence and recurrence due to widespread mucosal involvement. Verrucous growth patterns, often seen in subtypes like proliferative verrucous leukoplakia, are linked to aggressive persistence and frequent relapses despite intervention. Persistent on follow-up after treatment further worsens , indicating ongoing dysplastic changes that resist resolution. Patient-specific factors also play a critical role; advanced age over 60 years is associated with poorer outcomes, including higher rates, likely due to cumulative exposure and reduced regenerative capacity. Comorbidities such as exacerbate persistence and recurrence by impairing immune surveillance of premalignant changes. Prognostic factors may vary by region, with higher transformation risks in areas with prevalent betel quid chewing; recent 2025 studies explore molecular and AI-based models for better risk stratification. Recurrence rates following surgical excision range from 10% to 30%, with ongoing exposure to irritants like significantly elevating this risk by promoting lesion re-emergence. These factors collectively guide surveillance intensity, emphasizing the need for modification to optimize long-term outcomes.

History and Etymology

Historical Development

The term "leukoplakia" was first coined in 1861 by Austrian pathologist Karl Freiherr von Rokitansky to describe white lesions of the urinary tract. Its recognition as a distinct oral condition dates back to the late , when white patches on the were first systematically described in . In 1877, Hungarian dermatologist Ernst Schwimmer first applied the term "leukoplakia" to describe idiopathic white lesions of the oral mucous membranes, marking the initial clinical characterization of these plaques as potentially significant beyond mere . Earlier observations of similar oral white patches had been noted sporadically, but Schwimmer's work provided the foundational for oral lesions, emphasizing their persistence and association with chronic . In the early , research began linking leukoplakia to environmental factors, particularly use. By , experimental studies demonstrated that exposure to tobacco smoke could induce leukoplakia-like lesions in animal models, such as rabbits subjected to daily smoke inhalation, establishing a causal association that shifted perceptions from idiopathic origins to preventable . This period also saw growing epidemiological evidence from reports highlighting as a primary , influencing early preventive recommendations. The 1970s brought further standardization through the (WHO), which in 1978 defined oral leukoplakia as "a white patch or plaque that cannot be characterized clinically or pathologically as any other disease," while classifying it within oral precancerous conditions to underscore its malignant potential. The 1980s introduced a subtype with the discovery of oral hairy leukoplakia, first reported in by Greenspan et al. as a corrugated white lesion on the lateral tongue in patients with acquired immunodeficiency syndrome (AIDS), linked to Epstein-Barr virus replication in immunocompromised individuals. This finding expanded the understanding of leukoplakia variants and their ties to systemic diseases. Entering the , molecular studies illuminated genetic mechanisms, with research identifying gene mutations and protein overexpression in dysplastic leukoplakia tissues as predictors of progression to oral , as evidenced in longitudinal analyses of premalignant lesions. Recent advancements from 2020 to 2025 have focused on genomic and technological innovations. Genomic profiling studies have revealed recurrent alterations, such as at 9p and TP53 mutations, in progressing leukoplakia, enabling better risk stratification through next-generation sequencing. Concurrently, trials of AI-assisted have shown promise, with models achieving high accuracy in detecting and grading leukoplakia from clinical images and , as demonstrated in 2025 frameworks using convolutional neural networks on datasets of over 600 cases.

Etymology

The term "leukoplakia" derives from the Greek words leukos (λευκός), meaning "," and plax (πλάξ), meaning "plate" or "flat surface," literally translating to "white plate" or "white patch." It was first applied to oral white mucosal lesions in 1877 by the Hungarian dermatologist Ernst Schwimmer, initially encompassing any such appearance without regard to . Over the course of the 20th century, the nomenclature evolved to refine its application, particularly through the World Health Organization's 1978 definition, which specified leukoplakia as a white patch or plaque that cannot be clinically or pathologically characterized as any other disease, thereby excluding lesions with identifiable causes such as or frictional . Related terms include "leukokeratosis," a historical referring to the same keratotic white lesions of the . Site-specific variants, such as esophageal leukoplakia, extend the nomenclature to analogous white plaques in non-oral locations like the , though these remain rare and are sometimes termed epidermoid . Modern usage avoids outdated descriptors like "smoker's patch," which implied a direct causal link to without excluding other etiologies and has been supplanted by more precise, clinically neutral terminology.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.